188 related articles for article (PubMed ID: 21885166)
1. Optically active 1,3,4,4-tetrasubstituted β-lactams: synthesis and evaluation as tumor cell growth inhibitors.
Pérez-Faginas P; Aranda MT; García-López MT; Francesch A; Cuevas C; González-Muñiz R
Eur J Med Chem; 2011 Oct; 46(10):5108-19. PubMed ID: 21885166
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric synthesis of anticancer beta-lactams via Staudinger reaction: utilization of chiral ketene from carbohydrate.
Banik BK; Banik I; Becker FF
Eur J Med Chem; 2010 Feb; 45(2):846-8. PubMed ID: 19962794
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective synthesis of beta-lactams with polyaromatic imines: entry to new and novel anticancer agents.
Banik I; Becker FF; Banik BK
J Med Chem; 2003 Jan; 46(1):12-5. PubMed ID: 12502355
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of anticancer beta-lactams: mechanism of action.
Banik BK; Becker FF; Banik I
Bioorg Med Chem; 2004 May; 12(10):2523-8. PubMed ID: 15110834
[TBL] [Abstract][Full Text] [Related]
5. 1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Singh P; Raj R; Kumar V; Mahajan MP; Bedi PM; Kaur T; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):594-600. PubMed ID: 22071256
[TBL] [Abstract][Full Text] [Related]
6. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
7. N-Thiolated beta-lactam antibacterials: effects of the N-organothio substituent on anti-MRSA activity.
Heldreth B; Long TE; Jang S; Reddy GS; Turos E; Dickey S; Lim DV
Bioorg Med Chem; 2006 Jun; 14(11):3775-84. PubMed ID: 16480881
[TBL] [Abstract][Full Text] [Related]
8. β-Lactam synthon-interceded diastereoselective synthesis of functionalized octahydroindole-based molecular scaffolds and their in vitro cytotoxic evaluation.
Singh P; Raj R; Bhargava G; Hendricks DT; Handa S; Slaughter LM; Kumar V
Eur J Med Chem; 2012 Dec; 58():513-8. PubMed ID: 23164657
[TBL] [Abstract][Full Text] [Related]
9. Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction.
Banik BK; Banik I; Becker FF
Bioorg Med Chem; 2005 Jun; 13(11):3611-22. PubMed ID: 15862989
[TBL] [Abstract][Full Text] [Related]
10. Exceptional stereoselectivity in the synthesis of 1,3,4-trisubstituted 4-carboxy beta-lactam derivatives from amino acids.
Pérez-Faginas P; O'Reilly F; O'Byrne A; García-Aparicio C; Martín-Martínez M; Pérez de Vega MJ; García-López MT; Gonzalez-Muñiz R
Org Lett; 2007 Apr; 9(8):1593-6. PubMed ID: 17381101
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
12. Lead identification of β-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90.
O'Boyle NM; Knox AJ; Price TT; Williams DC; Zisterer DM; Lloyd DG; Meegan MJ
Bioorg Med Chem; 2011 Oct; 19(20):6055-68. PubMed ID: 21920765
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Zhang L; Fan J; Chong JH; Cesena A; Tam BY; Gilson C; Boykin C; Wang D; Aivazian D; Marcotte D; Xiao G; Le Brazidec JY; Piao J; Lundgren K; Hong K; Vu K; Nguyen K; Gan LS; Silvian L; Ling L; Teng M; Reff M; Takeda N; Timple N; Wang Q; Morena R; Khan S; Zhao S; Li T; Lee WC; Taveras AG; Chao J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5633-7. PubMed ID: 21798738
[TBL] [Abstract][Full Text] [Related]
15. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro anti-tubercular evaluation of 1,2,3-triazole tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone chimeric scaffolds.
Kumar K; Singh P; Kremer L; Guérardel Y; Biot C; Kumar V
Dalton Trans; 2012 May; 41(19):5778-81. PubMed ID: 22473422
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of cryptophycins via an N-acyl-beta-lactam macrolactonization.
Vidya R; Eggen M; Nair SK; Georg GI; Himes RH
J Org Chem; 2003 Dec; 68(25):9687-93. PubMed ID: 14656095
[TBL] [Abstract][Full Text] [Related]
19. Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin.
Zhou P; Liu Y; Zhou L; Zhu K; Feng K; Zhang H; Liang Y; Jiang H; Luo C; Liu M; Wang Y
J Med Chem; 2016 Nov; 59(22):10329-10334. PubMed ID: 27805821
[TBL] [Abstract][Full Text] [Related]
20. Gamma-lactones alpha,beta- and beta,gamma-fused to carbocycles as novel antiproliferative drugs.
León LG; Machín RP; Rodríguez CM; Ravelo JL; Martín VS; Padrón JM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5171-3. PubMed ID: 18789684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
